CY1116514T1 - SUSPENSIONS TOY NF-KB - Google Patents

SUSPENSIONS TOY NF-KB

Info

Publication number
CY1116514T1
CY1116514T1 CY20151100640T CY151100640T CY1116514T1 CY 1116514 T1 CY1116514 T1 CY 1116514T1 CY 20151100640 T CY20151100640 T CY 20151100640T CY 151100640 T CY151100640 T CY 151100640T CY 1116514 T1 CY1116514 T1 CY 1116514T1
Authority
CY
Cyprus
Prior art keywords
toy
suspensions
ischemia
recurrence
diabetes
Prior art date
Application number
CY20151100640T
Other languages
Greek (el)
Inventor
Jie Zhang
D Robert Sliskovic
Charles E Ducker
Original Assignee
Profectus Biosciences, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20100724601 external-priority patent/EP2411376B1/en
Application filed by Profectus Biosciences, Inc. filed Critical Profectus Biosciences, Inc.
Publication of CY1116514T1 publication Critical patent/CY1116514T1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Η εφεύρεση αναφέρεται σε ενώσεις των τύπων (1) και (2) και τα φαρμακευτικά αποδεκτά άλατα αυτών για τη θεραπεία του καρκίνου, της φλεγμονής, των αυτοάνοσων νοσημάτων, του διαβήτη και των διαβητικών επιπλοκών, της λοίμωξης, του καρδιαγγειακού νοσήματος και των βλαβών ισχαιμίας-επαναιμάτωσης.The invention relates to compounds of formulas (1) and (2) and their pharmaceutically acceptable salts for the treatment of cancer, inflammation, autoimmune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia. - recurrence.

CY20151100640T 2009-03-27 2015-07-21 SUSPENSIONS TOY NF-KB CY1116514T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16425609A 2009-03-27 2009-03-27
US25509609A 2009-10-27 2009-10-27
US26502609A 2009-11-30 2009-11-30
EP20100724601 EP2411376B1 (en) 2009-03-27 2010-03-25 Inhibitors of nf-kb

Publications (1)

Publication Number Publication Date
CY1116514T1 true CY1116514T1 (en) 2017-03-15

Family

ID=58459767

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100640T CY1116514T1 (en) 2009-03-27 2015-07-21 SUSPENSIONS TOY NF-KB

Country Status (1)

Country Link
CY (1) CY1116514T1 (en)

Similar Documents

Publication Publication Date Title
CY1120807T1 (en) COMPOSITIONS AND METHODS FOR MODIFICATION OF SMN2 ASSEMBLY TO A SUBJECT
CY1122629T1 (en) EICOSPENTAENOIC ACID ETHYL ESTER FOR THE TREATMENT OF HYPERTRIGLYCERIDEMIA
CY1122428T1 (en) THERAPEUTIC MANAGEMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH BISPECIFIC ANTIBODIES AGAINST CD3XCD19
CY1122713T1 (en) ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS
CY1121593T1 (en) TETRAHYDROCANNAVINOL PRODUCTS, COMPOSITIONS INCLUDING TETRAHYDROCANNAVINOL PRODUCTS AND METHODS FOR USING THE SAME
CY1122366T1 (en) TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
CY1124000T1 (en) SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES IN CRYSTALLINE FORM
CY1117312T1 (en) Therapeutic treatment of cochlecopenia
CY1120048T1 (en) COMPOSITIONS FOR THE treatment of gastrointestinal inflammation
CY1119252T1 (en) NEW PRODUCTS 1-BENZYLO-3-HYDROXYMETHYLUNDAZOLIS AND USE THESE IN CREATIVITY BASED ON CX3CR1 AND P40 EXPRESSION
CY1119616T1 (en) HUMAN ANTI-DUMP DRUG CONSUMPTION AGAINST TISSUE
CY1119684T1 (en) Anti-viral compounds
CY1119582T1 (en) HYDRAULIC INSULIN PREPARATIONS CONTAINING Methionine
CY1115180T1 (en) FABRY DISEASE TREATMENT OPTIONS
CY1119752T1 (en) HOLINESS CELLULAR CYLINDER OF EXALASTAT
GT200900095A (en) REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HERMATOLOGICAL DISEASES.
CY1112067T1 (en) USE OF FLIBANSERINE FOR THE TREATMENT OF PRE-MONOPOLY DISORDERS
CY1116057T1 (en) KINAZOLIN-4 (3H) -ONE DERIVATIVES USED AS RI3
EA201291336A1 (en) SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINE AND THEIR APPLICATION
EA201071144A1 (en) HETEROCYCLIC DERIVATIVES
CY1112320T1 (en) TAPENDADOL TITLE
CY1115254T1 (en) PHARMACEUTICAL SOLUTIONS, PROCEDURES FOR PREPARATION AND THERAPEUTIC USES
EA201190217A1 (en) SUBSTITUTED 2-ACETAMIDO-5-ARIL-1,2,4-TRIAZOLONES AND THEIR APPLICATION
EA201100910A1 (en) TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE BETA-DEFENSINS OF MAMMALS
CY1117603T1 (en) LIXISENATIDE AS AN ADDITION TO METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES